Suven Pharma Q2 net profit declines 20 per cent to Rs 74 cr

PTI | Updated on October 30, 2020 Published on October 30, 2020

Drug firm Suven Pharmaceuticals on Friday reported a 20.35 per cent decline in its consolidated net profit at Rs 74.07 crore for the quarter ended September 30, 2020.

The company had posted a net profit of Rs 93 crore for the corresponding period of the previous fiscal.

Consolidated total income of the company stood at Rs 237.74 crore for the quarter under consideration. It was Rs 278.37 crore for the same period year ago, it added.

“The board has allotted the bonus shares at 1:1 ratio in its meeting held on September 29, 2020,” the filing said.

The board has approved capital expenditure (capex) plan of Rs 600 crore keeping in view of the proposed increase in capacity in Pashamylaram facility, replacement and modernization of production blocks in Suryapet facility, relocation of R&D facilities from Jeedimetla and acquisition of new technologies, it added.

Shares of Suven Pharmaceuticals were trading at Rs 308.70 per scrip on BSE, down 8.86 per cent from its previous close.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on October 30, 2020
This article is closed for comments.
Please Email the Editor